RapidAI and Amazon Web Services (AWS) have announced a strengthened partnership aimed at accelerating the global deployment of deep clinical AI in healthcare. The collaboration builds on RapidAI’s FDA clearances, enterprise AI leadership, and expanding international presence, combining AWS’s robust cloud infrastructure with RapidAI’s clinical expertise and multimodal healthcare data. At RSNA 2025, the two companies will showcase the Rapid Edge Cloud™, the only cloud-native platform with on-prem capabilities, ensuring secure, continuous operation in any clinical setting. Built on AWS’s global infrastructure, the platform supports hospitals in over 100 countries, enabling seamless AI deployment while meeting strict regional data privacy, security, and compliance standards. Dr. Rowland Illing, Global Chief Medical Officer and Director of Healthcare and Life Sciences at AWS, highlighted the importance of combining clinical intelligence with scalable technology. “RapidAI is advancing the frontier of clinical AI by pairing domain-specific intelligence with scalable cloud infrastructure,” he said. “By building on AWS, they are helping hospitals accelerate AI-driven care delivery with confidence, resilience, and measurable clinical impact.” The partnership focuses on co-developing advanced AI solutions and foundational model infrastructure to drive clinical innovation. By integrating AWS’s scalable machine learning pipelines with RapidAI’s deep clinical knowledge and disease-specific algorithms, the companies aim to deliver more adaptive, clinically validated AI tools that enhance diagnostic accuracy, streamline workflows, and expand access to life-saving technologies worldwide. Karim Karti, CEO of RapidAI, emphasized the power of the collaboration. “AWS provides the trusted global infrastructure that allows RapidAI to deliver deep clinical AI at scale, securely, reliably, and without compromise,” he said. “Together, we’re combining clinical depth with cloud scale, ensuring hospitals can harness powerful AI-driven insights no matter where they are in the world.” RapidAI’s Rapid Enterprise™ Platform, which powers solutions like Rapid Aneurysm™, Lumina 3D™, and Rapid Aortic, demonstrates the real-world impact of this approach. For example, Lumina 3D automates 3D CTA reconstruction for head and neck scans, saving a midwestern health system 24 minutes per scan—freeing up 72 hours of technologist time monthly and enabling five additional scans per day. This translated to $61,000 in incremental imaging revenue each month. Raza Mushtaq, MD, a neuroradiologist at the Barrow Neurological Institute, noted the clinical and operational benefits. “With Lumina 3D, we’ve not only improved turnaround time but reduced the cognitive burden on our team,” he said. “Automation eliminates repetitive manual work, delivers consistent high-quality reconstructions, and gives our staff the time and mental bandwidth to focus on interpretation and patient care. The impact has been substantial.” This enhanced integration supports RapidAI’s growing global footprint and follows key milestones, including multiple FDA clearances, new product launches, and expanding enterprise deployments. Together, RapidAI and AWS are setting a new benchmark for secure, scalable, and clinically meaningful AI in healthcare. RapidAI is the trusted leader in deep clinical AI, helping hospitals deliver faster, more informed care through intelligent imaging and integrated workflows. Used by over 2,500 hospitals in more than 100 countries and backed by 700+ clinical studies—including research that influenced national stroke treatment guidelines—RapidAI is the most clinically validated AI platform in healthcare. Learn more at rapidai.com.